Atlas Trials

The PRELUDE BTK Study

Clinical trial NCT03693963 · COMPLETED

Trial details

NCT number
NCT03693963
Sponsor
Cagent Vascular LLC
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Peripheral Arterial DiseaseCritical Limb Ischemia
Start date
2019-12-17
Primary completion
2020-04-11
Enrollment
49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.